Skip to main content
. 2020 Apr 16;10:6560. doi: 10.1038/s41598-020-63482-x

Figure 3.

Figure 3

CDDO-Me increases the proportion of CD8+ T cells and reduces Treg numbers in tumors in vivo. Whole mammary/tumor tissue of mice fed diet with or without 50 mg/kg CDDO-Me for 8 weeks was digested to a single cell suspension and analyzed by multicolor flow cytometry for analysis of CD4 + and CD8+ T cell populations (a). Dual positive CD4/Foxp3 T cell percentages were compared in control and CDDO-Me-treated mice (b). Expression of PD1 on CD8+ T cells was assessed using mean fluorescence intensity (MFI) (b). Where indicated, expression of surface markers is represented as percentage of cells positive for the respective marker (n = 5–10 per group). *p < 0.05, **p < 0.01, ***p < 0.005 vs. vehicle.